Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

FDA awards over $38m for advancement of rare disease treatments

Grants will support clinical trials, natural history studies and regulatory science tools

- PMLiVE

New study identifies gene associated with strong immune response to COVID-19 vaccines

Two out of every five people in the UK carry a version of an HLA gene called HLA-DQB1*06

- PMLiVE

Kite’s CAR-T therapy Yescarta granted EC approval in second-line lymphoma

The decision is based on results from the phase 2 ZUMA-7 study

- PMLiVE

Reimbursement ≠ patient access

By Toby Gunner

- PMLiVE

A Look at What’s Next After ESC

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

Medscape Education

- PMLiVE

Medscape Medical Affairs are PMEA Finalists in Three Categories

The Pharmaceutical Market Excellence Awards (PMEA) have announced that Medscape Medical Affairs is a finalist in their 2022 awards for their entry Transatlantic Exchanges: Driving Therapeutic Innovation in Oncology for...

Medscape Medical Affairs

- PMLiVE

Antimicrobial resistance – the silent pandemic

By Isabella Talbot

- PMLiVE

Gilead and MacroGenics enter $1.7bn oncology partnership

The collaboration will focus on developing bispecific antibodies

- PMLiVE

Moderna and Gavi update COVAX supply deal to include variant-specific COVID-19 vaccines

The agreement aims to ensure equitable access to low- and middle- income countries

- PMLiVE

UK Government announces £800m boost to support innovation and improve patient safety

The funding will be distributed by the National Institute for Health and Care Research

- PMLiVE

Takeda’s dengue vaccine candidate recommended for approval by CHMP

Dengue disease causes around 390 million infections and 500,000 hospitalisations each year

- PMLiVE

New study finds signs of dementia could be detected nine years before diagnosis

Impairment was observed in several areas across a range of dementia-related diseases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links